Literature DB >> 26801975

Ebola vaccine will be made available for emergency use.

Anne Gulland1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26801975     DOI: 10.1136/bmj.i386

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  2 in total

1.  Rapid Establishment of a Cold Chain Capacity of -60°C or Colder for the STRIVE Ebola Vaccine Trial During the Ebola Outbreak in Sierra Leone.

Authors:  Morrison O Jusu; Geoffrey Glauser; Jane F Seward; Mohamed Bawoh; Judith Tempel; Michael Friend; Daniel Littlefield; Michael Lahai; Hassan M Jalloh; Amara Bangali Sesay; Amanda F Caulker; Mohamed Samai; Vasavi Thomas; Nicholas Farrell; Marc-Alain Widdowson
Journal:  J Infect Dis       Date:  2018-05-18       Impact factor: 5.226

2.  The Sierra Leone Trial to Introduce a Vaccine Against Ebola: An Evaluation of rVSV∆G-ZEBOV-GP Vaccine Tolerability and Safety During the West Africa Ebola Outbreak.

Authors:  Mohamed Samai; Jane F Seward; Susan T Goldstein; Barbara E Mahon; Durodami Radcliffe Lisk; Marc-Alain Widdowson; Mohamed I Jalloh; Stephanie J Schrag; Ayesha Idriss; Rosalind J Carter; Peter Dawson; S A S Kargbo; Bailah Leigh; Mohamed Bawoh; Jennifer Legardy-Williams; Gibrilla Deen; Wendy Carr; Amy Callis; Robert Lindblad; James B W Russell; Carey R Petrie; Augustin E Fombah; Brima Kargbo; Wendi McDonald; Olamide D Jarrett; Robert E Walker; Paul Gargiullo; Donald Bash-Taqi; Laura Gibson; Abu Bakarr Fofanah; Anne Schuchat
Journal:  J Infect Dis       Date:  2018-05-18       Impact factor: 5.226

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.